Cargando…
Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206358/ https://www.ncbi.nlm.nih.gov/pubmed/37225686 http://dx.doi.org/10.1038/s41392-023-01485-6 |
| _version_ | 1785046212287660032 |
|---|---|
| author | Li, Gen Yu, Meixing Ke, Qiong Sun, Jing Peng, Yanwen Xiong, Chuanfeng Monteiro, Olivia Zhao, Jincun Xiang, Andy P. |
| author_facet | Li, Gen Yu, Meixing Ke, Qiong Sun, Jing Peng, Yanwen Xiong, Chuanfeng Monteiro, Olivia Zhao, Jincun Xiang, Andy P. |
| author_sort | Li, Gen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10206358 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102063582023-05-25 Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant Li, Gen Yu, Meixing Ke, Qiong Sun, Jing Peng, Yanwen Xiong, Chuanfeng Monteiro, Olivia Zhao, Jincun Xiang, Andy P. Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-05-24 /pmc/articles/PMC10206358/ /pubmed/37225686 http://dx.doi.org/10.1038/s41392-023-01485-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Li, Gen Yu, Meixing Ke, Qiong Sun, Jing Peng, Yanwen Xiong, Chuanfeng Monteiro, Olivia Zhao, Jincun Xiang, Andy P. Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title | Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title_full | Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title_fullStr | Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title_full_unstemmed | Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title_short | Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant |
| title_sort | enhancement of sars-cov-2 vaccine-induced immunity by a toll-like receptor 7 agonist adjuvant |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206358/ https://www.ncbi.nlm.nih.gov/pubmed/37225686 http://dx.doi.org/10.1038/s41392-023-01485-6 |
| work_keys_str_mv | AT ligen enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT yumeixing enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT keqiong enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT sunjing enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT pengyanwen enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT xiongchuanfeng enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT monteiroolivia enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT zhaojincun enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant AT xiangandyp enhancementofsarscov2vaccineinducedimmunitybyatolllikereceptor7agonistadjuvant |